Register Login

BIORESTORATIVE THERAPIES, INC. (BRTX)

SymbolBRTX
NameBIORESTORATIVE THERAPIES, INC.
SectorHEALTH CARE
RegionNorth America
IndustryManaged Health Care
Address40 MARCUS DRIVE, MELVILLE, New York, 11747, United States
Telephone+1 631 760-8100
Fax—
Email—
Websitehttps://www.biorestorative.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK—
Description

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The companys two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patients bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Additional info from NASDAQ:
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The companys two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patients bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

2026-04-30 14:36

BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform

Read more
2026-04-29 07:08

New Form EFFECT - BioRestorative Therapies, Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 9999999995-26-001353 <b>Size:</b> 1 KB

Read more
2026-04-27 17:06

New Form POS AM - BioRestorative Therapies, Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001493152-26-019129 <b>Size:</b> 244 KB

Read more
2026-04-23 21:12

(99% Neutral) BIORESTORATIVE THERAPIES, INC. (BRTX) Files Form 8-K

Read more
2026-04-20 18:30

New Form POS AM - BioRestorative Therapies, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001493152-26-018143 <b>Size:</b> 586 KB

Read more
2026-04-13 18:22

New Form DEF 14A - BioRestorative Therapies, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001021771-26-000042 <b>Size:</b> 2 MB

Read more
2026-04-07 12:15

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform

Read more
2026-04-03 15:47

New Form PRE 14A - BioRestorative Therapies, Inc. <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 0001021771-26-000039 <b>Size:</b> 109 KB

Read more
2026-04-03 02:34

BRTX attributes changed: Attr: Fin_status N -> D;

Read more
2026-04-03 02:34

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Read more